✦ LIBER ✦

A Randomized Phase II Study of Sorafenib/Gemcitabine or Sorafenib/Erlotinib for Advanced Non–Small-Cell Lung Cancer in Elderly Patients or Patients with a Performance Status of 2: Treatment Rationale and Protocol Dynamics

✍ Scribed by Cesare Gridelli; Antonio Rossi; Floriana Mongillo; Maria Bareschino; Paolo Maione; Fortunato Ciardiello

Book ID: 119935558
Publisher: CIG Media Group, LP.
Year: 2007
Tongue: English
Weight: 108 KB
Volume: 8
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2007.n.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sorafenib in combination with erlotinib

Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study

✍ Gridelli, C.; Morgillo, F.; Favaretto, A.; de Marinis, F.; Chella, A.; Cerea, G. 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 125 KB

Randomized Phase II Trial of Erlotinib o

Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients With Advanced Non-Small-Cell Lung Cancer and a Performance Status of 2

✍ Lilenbaum, R.; Axelrod, R.; Thomas, S.; Dowlati, A.; Seigel, L.; Albert, D.; Wit 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 205 KB

A Randomized Phase II Study of Pemetrexe

A Randomized Phase II Study of Pemetrexed or RAD001 as Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer in Elderly Patients: Treatment Rationale and Protocol Dynamics

✍ Cesare Gridelli; Antonio Rossi; Floriana Morgillo; Maria Anna Bareschino; Paolo 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 104 KB

Randomized, Double-Blind, Placebo-Contro

Randomized, Double-Blind, Placebo-Controlled, Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer

✍ Spigel, D. R.; Burris, H. A.; Greco, F. A.; Shipley, D. L.; Friedman, E. K.; Wat 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 161 KB

Gemcitabine (GEM) and Vindesine (VDS) in

Gemcitabine (GEM) and Vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): A phase II study in elderly or poor performance status patients

✍ Santo, Antonio; Genestreti, Giovenzio; Terzi, Alberto; Azzoni, Paolo; Sava, Teod 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Randomized phase II trial of gefitinib o

Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study)

✍ Morère, Jean-François; Bréchot, Jeanne-Marie; Westeel, Virginie; Gounant, Valeri 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 483 KB